Bangalore-based Sami Labs Ltd, a Rs 250 crore health science
organisation has got patents for three new active ingredients
- Tetrahydrocurcuminoids (THC), Coleus oil and ZeaLutien.
These have applications in the dermatology, infective and
geriatric ophthalmology markets.
company has got approval for these three active ingredients
recently, said a company release.
3 active ingredients in nutraceuticals and cosmeceuticals
formulations have a combined estimated market size of Rs
20 crore. Sami Labs hopes to capture 5 per cent of the total
market in the next three years with these discoveries.
Labs has so far invested close to Rs 60 crore in four production
units at Bangalore, Singasandra, Kunigal and Mysore, the
release said. It also has a research facility at Bangalore.
company is also involved in biotech research in probiotics
and is expected to roll out products by the end of 2004.
It is targeting Rs 100 crore turnover for its formulations
business in India by the close of 2006.